Searched for
NEW CHOLESTEROL PILL
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- New daily pill could slash Cholesterol for patients who don’t respond to Statins, study findsA new pill called Enlicitide may help people who don’t get results from statins. The drug showed big drops in bad cholesterol in early test...
- Lilly pill cuts body weight by 10.5% in patients with type 2 diabetesEli Lilly's new pill shows promise. The drug helped people with diabetes lose weight in trials. The pill, orforglipron, led to a 10.5% weig...
- Eli Lilly's experimental GLP-1 pill may rival Ozempic and Wegovy? Check how much weight you could loseEli Lilly's experimental weight loss pill, orforglipron, demonstrated an average weight loss of 12% in a late-stage trial, falling short of...
- One pill for 3 drugs: Researchers develop polypill to make life easier for heart patientsThe so-called polypill that combines three drugs needed to prevent cardiovascular trouble.
- Male contraceptive pill found 99% effective in miceEver since the female birth control pill was first approved in the 1960s, researchers have been interested in a male equivalent.
- Daily 'super pill' to prevent heart attacks and strokesThe largest ever analysis on the use of a polypill in cardiovascular disease shows potential for improvements in patient care, researchers ...
- Pfizer looking for Indian cos to partner in treating cancer patientsPfizer has identified oncology as the therapeutic segment for research in emerging markets such as China and India as cancer is one of the ...
- Ranbaxy Laboratories may sell Lipitor rights if FDA delays nodFederal prosecutors are negotiating a dispute settlement that may cost Ranbaxy more than $1 billion, Fortune Magazine reported in May.
- Merck Q1 sales rise but profit fall on chargesDrugmaker Merck & Co. says double-digit sales growth for a half-dozen of its top medicines fueled a 7 percent jump in first-quarter sales.
- Stocks to watch: Tata Power, Reliance Infra, Arvind Mills, Sundaram FinanceTata Power and Reliance Infrastructure have been locked in an escalating and bitter war of words over the terms of supply of power to Mumba...
- Glenmark gets a boost in cholesterol drug battle with MerckGlenmark Pharmaceuticals has gained the upper hand in a legal battle against Merck over a cholesterol control pill after a US court rejecte...
- Cancer fears may spark decline in Vytorin salesSales of Merck & Co and Schering-Plough Corp’s Vytorin, falling after data earlier this year questioned its effectiveness against a cheaper...
- DRL’s anti-diabetes drug to hit market by ’11Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...
- Pfizer's profit falls on costs to end diabetic treatment salesPfizer, the world’s largest drugmaker, said third-quarter profit fell 77% on costs for ending sales of the diabetes treatment Exubera and c...
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
- Ranbaxy gains double on high US salesRanbaxy Laboratories’ net profit doubled to Rs 520 crore in December 2006, spurred by US sales of its copy of Merck & Co’s cholesterol-lowe...
- Ranbaxy faces another setback in Lipitor battleRanbaxy’s $12bn dream to bust Pfizer’s monopoly over its cholesterol-lowering pill Lipitor has suffered yet another setback with the US Cou...
Load More
